pharmacie et médicaments – Modalités de substitution par un médicament biosimilaire pour les pharmaciens

This written question concerns the rules and conditions under which pharmacists can substitute a prescribed medication with a biosimilar alternative. It seeks clarification on the scope of their substitution powers. The question aims to understand the implications for patients, healthcare providers, and the pharmaceutical industry, particularly regarding access to affordable medicines and therapeutic continuity.